Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Ceramide: a common pathway for atherosclerosis?Bismuth J; Lin P; Yao Q; Chen CAtherosclerosis 2008[Feb]; 196 (2): 497-504Plasma sphingomyelin concentration is correlated with the development of atherosclerosis. It has been found to exist in significantly higher concentrations in aortic plaque. This appears to have clinical relevance as well as it has been shown to be an independent predictor of coronary artery disease. Ceramide, the backbone of sphingolipids, is the key component which affects atherosclerotic changes through its important second-messenger role. This paper sheds light on some of the current literature supporting the significance of ceramide with respect to its interactions with lipids, inflammatory cytokines, homocysteine and matrix metalloproteinases. Furthermore, the potential therapeutic implications of modulating ceramide concentrations are also discussed.|Atherosclerosis/drug therapy/*etiology[MESH]|Ceramides/*blood[MESH]|Fatty Acids, Monounsaturated/therapeutic use[MESH]|Homocysteine/blood[MESH]|Humans[MESH]|Matrix Metalloproteinases/physiology[MESH]|Nitric Oxide/physiology[MESH]|Reactive Oxygen Species/metabolism[MESH]|Sphingomyelin Phosphodiesterase/physiology[MESH]|Sphingomyelins/biosynthesis/blood[MESH]|Tumor Necrosis Factor-alpha/physiology[MESH] |
